OMDM-6
OMDM-6 is a hybrid agonist of vanilloid receptor type 1 (VR1, TRPV1) (EC50=75 nM) and cannabinoid receptor type 1 (CB1) (Ki=3.2 μM) . OMDM-6 inhibits anandamide cellular uptake (ACU) with a Ki of 7.0 μM[1].
Product Specifications
CAS Number
616884-67-4
UNSPSC
12352005
Target
Cannabinoid Receptor; Endogenous Metabolite; TRP Channel
Type
Reference compound
Related Pathways
GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/omdm-6.html
Concentration
10mM
Solubility
10 mM in DMSO
Smiles
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(NNCC1=CC=C(O)C(OC)=C1)=O
Molecular Formula
C28H42N2O3
Molecular Weight
454.64
References & Citations
[1]Ortar G, et al. Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol. 2003 May 1;65 (9) :1473-81.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PRDM4 (PR Domain Containing 4, MGC45046, PFM1) (MaxLight 650)
PRDM4 (PR Domain Containing 4, MGC45046, PFM1) (MaxLight 650)